Table 1. Age, gender, time after surgery and medical condition summary for experimental groups.
| NW | RYGB | LAGB | PreB-Ob | |
|---|---|---|---|---|
| Number of participants | 10 | 24 | 14 | 15 |
| Age | 42±15 | 51±7 | 46±11 | 50±9 |
| Gender (F/M) | 7/3 | 16/8 | 14/2 | 8/7 |
| Time after surgery (months) | NA | 35± 8 | 34±12 | NA |
| Diabetes (# of positives) | 0 | 0 | 2 | 7 |
| Hyperlipidemia (# of positives) | 0 | 3 | 6 | 7 |
| Hypertension (# of positives) | 0 | 6 | 3 | 9 |
| Arthritis (# of positives) | 0 | 7 | 3 | 8 |
Abbreviations: F, female; LAGB, laparoscopic adjustable gastric banding; M, male; NA, not applicable; NW, normal weight, PreB-Ob, pre-bariatric surgery morbidly obese; RYGB, Roux-en-Y gastric bypass.
For age and time after surgery categories, the numbers represent median values with median absolute deviation.